4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-053105
Chief Executive Officer acquired 10,000 shares (conversion)
- Chief Executive Officer gave 10,000 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
Gibson Christopher · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-16 | Conversion : show line 1 in the form | +10,000 | 852,747 | D |
| 2023-10-16 | Gift : show line 2 in the form | −10,000 | 842,747 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-16 | Conversion : show line 3 in the form Class B Common Stock | −10,000 | $0.00 | 10,000 | 6,501,496 | D |
Loading xslF345X05/doc4.xml…